:: Volume 20, Issue 1 (Bimonthly 2016) ::
Feyz 2016, 20(1): 11-15 Back to browse issues page
Effect of methanolic extract of hawthorn (Crataegus aronia) fruit on Leishmania major in vitro
Yahya Maroufi , Mansoor Dabirzadeh , Seyyed Hasan Hossein-Pour-Mousavi
Kurdistan University of Medical Sciences , maroofi.y@gmail.com
Abstract:   (4669 Views)

Background: Pentavalent antimonate compounds are the routine drugs for leishmaniasis. Apart from side effects, relapse and drug resistance are among the main problems of these compounds. Hawthorn has antioxidant and antibacterial effects. The aim of  present study was to determine the anti-leishmanial effect of hawthorn fruit extract in vitro.

Materials and Methods: In this experimental study different doses of hawthorn fruit extract was added to Leishmania major promastigotes. Cytotoxicity was investigated by both direct counting and MTT assay after 24, 48 and 72 hours. In addition, hawthorn extract was added to amastigote-infected macrophages and then the mean of amastigote per macrophage was counted after 24 and 48 hours. Data were analyzed using one-way ANOVA.

Results: The cytotoxicity of the highest and lowest concentration of the extract (60 µg/ml and 0.5 µg/ml) after 24, 48 and 72 hours was 31.86%, 27.93%; 20.11%, 20.94%; and 35.19%, 55.14%, respectively. After 24 hours the IC50 was 49.13 μg/ml; the mean number of amastigote per macrophage in Control and Plant extract-treated groups (1, 10 and 100 μg/ml) were: 3.91; (1.97, 1.76 and 1.78), respectively.

Conclusion: The results showed that hawthorn fruit extract has no significant cytotoxic effect on promastigotes. However, to some extent it can inhibit the proliferation of amastiogtes inside macrophages.

Keywords: Hawthorn, Leishmania major, Promastigote, Amastigote
Full-Text [PDF 220 kb]   (1754 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2016/04/11 | Revised: 2017/08/2 | Accepted: 2016/04/11 | Published: 2016/04/11
References
1. Singh N, Kumar M, Singh RK. Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pac J Trop Med 2012; 5(6): 485-97.
2. Hepburn NC. Cutaneous leishmaniasis. Clin Exp Dermatol 2000; 25(5): 363-70.
3. Postigo JA. Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Int J Antimicrob Agents 2010; 36 Suppl 1: 62-5.
4. Bermarn JD. Human leishmaniasis: clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997; 24(4): 684–703.
5. Athari A, Jalallu N. Epidemiological survey of cutaneous leishmaniasis in Iran 2001-2005. Sci J Isfahan Univ Med Sci 2006; 24(82): 8–13. [in Persian]
6. Hewaldt BL. Leishmaniasis. Lancet 1999; 354(9185): 1191–9.
7. Moskowitz PF, Kurban AK. Treatment of cutaneous leishmaniasis: retrospectives and advances for the 21st century. Clin Dermatol 1999; 17(3): 305–15.
8. Santos DO, Coutinho CE, Madeira MF, Bottino CG, Vieira RT, Nascimento SB, et al. Leishmaniasis treatment-a challenge that remains: a review. Parasitol Res 2008; 103(1): 1-10.
9. Saldanha AC, Romero GA, Merchan-Hamann E, Magalhães AV, Macedo Vde O. A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety. Rev Soc Bras Med Trop 1999; 32(4): 383-7.
10. Kobets T, Grekov I, Lipoldova M. Leishmaniasis: prevention, parasite detection and treatment. Curr Med Chem 2012; 19(10): 1443-74.
11. Benmalek Y, Yahia OA, Belkebir B, Fardeau ML. Anti-microbial and anti-oxidant activities of Illicium verum, Crataegus oxyacantha ssp monogyna and Allium cepa red and white varieties. Bioengineered 2013; 4(4): 244–8.
12. Djeddi S, Boutaleb H. Evaluation of antioxidative and antibacterial potentials of Crataegus monogyna Jacq. from Mahouna mountain (Algeria). J Advanced Sci Applied Engineering 2014; 1(1): 60-3.
13. Kao ES, Wang CJ, Lin WL, Yin YF, Wang CP, Tseng TH. Anti-inflammatory potential of flavonoid contents from dried fruit of crataegus pinnatifida in vitro and in vivo. J Agric Food Chem 2005; 53(2): 430-36.
14. Shahat AA, Cos P, De Bruyne T, Apers S, Hammouda FM, Ismail SI, , et al. Antiviral and antioxidant activity of flavonoids and proanthocyanidins from Crataegus sinaica. Planta Med 2002; 68(6): 539-41.
15. Kostic DA, Velickovic JM, Mitic SS, Mitic MN, Randelovic SS. Phenolic Content, and Antioxidant and Antimicrobia Activities of Crataegus Oxyacantha L (Rosaceae) Fruit Extract from Southeast Serbia. Trop J Pharm Res 2012; 11(1): 117-24.
16. Ignat I, Radu DG, Volf I, Pag AI, Popa VI. Antioxidant and antibacterial activities of some natural polyphenols. Cell Chem Technol 2013; 47 (5-6): 387-99.
17. Schüssler M, Hölzl J, Fricke U. Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung 1995; 45(8): 842-45.
18. Maroufi Y, Ghaffarifar F, Dalimi A, Sharifi Z, Hasan Z. A study on the cytotoxic effect of cantharidin on Leishmania majorpromastigote and amastigote survival in vitro. Feyz 2012; 16(5): 406-13. [in Persian]
19. Maroufi Y, Ghaffarifar F, Dalimi A, Sharifi Z, Hassan Z. Cantharidin-induced apoptosis in Leishmania major promastigotes and macrophages infected by Leishmania major amastigotes in vitro. J Mazandaran Univ Med Sci 2012; 22(89): 32-40. [in Persian]
20. Salmanian S, Sadeghi AR, Alami M, Ghorbani M. Phenolic Content, Antiradical, Antioxidant, and Antibacterial Properties of Hawthorn (Crataegus elbursensis) Seed and Pulp Extract. J Agr Sci Tech 2014; 16(2): 343-54.
21. Asadi M, Bahrami S, Ansari Samani R, Pakniat N. Effect of hydroalcoholic extracts of Stachys lavandulifolia Vahl and Mespilus germanica leaves on Leishmania major. J Med Hormozgan 2012 15(4): 279-84. [in Persian]
22. Shariatifar N, Rahimnia R, Jamshidi AM, Pirali Hamedani M, Shoeibi Sh. Effect of Ethanolic Extract of Mespilus germanica on Cutaneous Leishmaniasis in BALB/c Mice. J Med Plans 2010; 10(39): 76-81.
23. Yousefi R, Ghaffarifar F, Dalimi A. The Effect of Alkanna tincturia and Peganum harmala Extracts on Leishmania major (MRHO/IR/75/ER) in vitro. Iran J Parasitol 2009; 4(1): 40-7.


XML   Persian Abstract   Print



Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 20, Issue 1 (Bimonthly 2016) Back to browse issues page